Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting approximately 10% of women of reproductive age in the UK
Not another pill to swallow or powder to mix into water
is on the advisory board and does consultancy and lectures for NovoNordisk, AstraZeneca, Sanofi, Boehringer, Lilly, Mundipharma and Sankyo
Gastrointestinal side effects may be serious enough to force patients to stop treatment, thus limiting the effectiveness of these medications [7]
The 'peptide didn't work' complaints we see online are, in our experience, storage failures 6070% of the time
Species differences in receptor biology, metabolic rate, thermogenic capacity, pharmacokinetics, and peptide handling materially affect interpretation